Cohort Study of Pioglitazone and Bladder Cancer in Patients With Diabetes

Trial Profile

Cohort Study of Pioglitazone and Bladder Cancer in Patients With Diabetes

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Jan 2016

At a glance

  • Drugs Pioglitazone (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Sponsors Takeda
  • Most Recent Events

    • 09 Sep 2014 Status changed from active, no longer recruiting to completed.
    • 28 Aug 2014 Final 10-year results published in the Media Release.
    • 31 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top